Related Experiment Video
Updated: Jul 9, 2026

13:51
The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
16.0K
Bac to Bac System Efficiency for Preparing HPV Type 16 Virus-Like Particle Vaccine
H Razavi-Nikoo1, E Behboudi2, B Aghcheli1
1Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran.
Archives of Razi Institute
|November 29, 2023
Summary
This study demonstrates the successful production of human papillomavirus (HPV) L1 virus-like particles (VLPs) using a baculovirus expression system in insect cells. This method offers a promising avenue for the industrial-scale synthesis of HPV L1 protein for vaccine development.
Area of Science:
- Biotechnology
- Virology
- Molecular Biology
Background:
- The L1 protein of human papillomavirus (HPV) is a key target for prophylactic vaccines.
- Virus-like particles (VLPs) mimicking natural HPV structure are crucial for inducing neutralizing antibodies.
- Eukaryotic expression systems are vital for producing functional HPV L1 protein.
Purpose of the Study:
- To utilize the Bac-to-Bac system for generating HPV16 L1 VLPs in Spodoptera frugiperda (Sf9) insect cells.
- To optimize the industrial-level production of HPV L1 protein.
- To assess the suitability of the baculovirus/Sf9 system for recombinant protein synthesis.
Main Methods:
- Selected and codon-optimized the wild-type HPV16 L1 gene.
- Constructed a recombinant baculovirus using the pFast Bac vector and Bac-to-Bac system.
- Transfected Sf9 cells, lysed cells, and analyzed L1 protein expression via SDS-PAGE and Western Blot.
- Purified L1 protein using Ni-NTA chromatography.
- Visualized VLP formation using transmission electron microscopy.
Main Results:
- Successfully expressed recombinant HPV16 L1 protein (~60 kD) in Sf9 cells.
- Confirmed L1 protein expression using SDS-PAGE and Western Blot with a specific monoclonal antibody.
- Transmission electron microscopy verified the assembly of VLPs.
- Demonstrated the efficacy of the baculovirus/Sf9 system for HPV L1 VLP production.
Conclusions:
- The baculovirus/Sf9 expression system is a viable and promising method for producing HPV16 L1 VLPs.
- This system facilitates industrial-scale production and optimization of HPV L1 protein synthesis.
- The characterized VLPs are suitable for further development in prophylactic HPV vaccine strategies.

